(Q37374196)

20 August 2017

1 reference

title

Perspectives on early communication of drug risks to the public (English)

1 reference

20 August 2017

P J Seligman

1

1 reference

20 August 2017

S F Osborne

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

21 January 2009

1 reference

Clinical Pharmacology & Therapeutics

20 August 2017

published in

1 reference

20 August 2017

volume

85

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

335-339

1 reference

Communicating the risks and benefits of medicines

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.272

Communicating information about drug safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.272

Drug warnings that can cause fits--communicating risks in a data-poor environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.272

Improving communication of drug risks to prevent patient injury: proceedings of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.272

The challenge of effectively communicating patient safety information

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.272

7 January 2021

The challenge of effectively communicating risk-benefit information

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.272

7 January 2021

Communicating foodborne disease risk

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.272

7 January 2021

Communicating safety information to physicians: an examination of dear doctor letters

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.272

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.272

1 reference

20 August 2017

1 reference